{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:26:15Z","timestamp":1791411975734,"version":"4.3.3"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001454","name":"American Epilepsy Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001454","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001605","name":"Epilepsy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jconrel.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T08:25:37Z","timestamp":1467966337000},"page":"147-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":161,"special_numbering":"C","title":["A review of intranasal formulations for the treatment of seizure emergencies"],"prefix":"10.1016","volume":"237","author":[{"given":"Mamta","family":"Kapoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Cloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9591-1282","authenticated-orcid":false,"given":"Ronald A.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.07.001_bb0005","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bmj.331.7518.673","article-title":"Status epilepticus: an evidence based guide","volume":"331","author":"Walker","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WCO.0000000000000307","article-title":"Recent advances in stratus epilepticus","volume":"29","author":"Trinka","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0015","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00004691-199512040-00003","article-title":"Epidemiology of status epilepticus","volume":"12","author":"DeLorenzo","year":"1995","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0020","first-page":"469","article-title":"Management of status epilepticus","volume":"68","author":"Sirven","year":"2003","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11940-005-0035-x","article-title":"Treatment of convulsive and nonconvulsive status epilepticus","volume":"7","author":"Pang","year":"2005","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0030","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0035","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/epi.12373","article-title":"A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures","author":"Abou-Khalil","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0196-0644(94)70034-6","article-title":"Rectal diazepam for prehospital pediatric status epilepticus","volume":"23","author":"Dieckmann","year":"1994","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(05)66909-7","article-title":"Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial","volume":"366","author":"McIntyre","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5698\/1535-7597-14.3.147","article-title":"Hope for new treatments for acute repetitive seizures","volume":"14","author":"Spencer","year":"2014","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0378-5173(02)00554-9","article-title":"The enhancement effect of surfactants on the penetration of lorazepam through rat skin","volume":"250","author":"Nokhodchi","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0378-5173(86)90036-0","article-title":"Transdermal delivery of anxiolytics: in vitro skin permeation of midazolam maleate and diazepam","volume":"33","author":"Touitou","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1742-7843.2008.00326.x","article-title":"Comparison of the Intramuscular, Intranasal or Sublingual Routes of Midazolam Administration for the Control of Soman-Induced Seizures","volume":"104","author":"McDonough","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0070","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1023\/A:1016255408348","article-title":"Enhanced transdermal delivery of diazepam by submicron emulsion (SME) creams","volume":"12","author":"Schwarz","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0075","first-page":"140","article-title":"Intranasal delivery: an approach to bypass the blood brain barrier","volume":"36","author":"Talegaonkar","year":"2004","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0080","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0085","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/mp100029t","article-title":"Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures","volume":"7","author":"Johnson","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0090","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jconrel.2012.01.024","article-title":"Nasal drug delivery - recent developments and future prospects","volume":"161","author":"Illum","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jps.20718","article-title":"Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?","volume":"96","author":"Illum","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1089\/jam.2006.19.92","article-title":"Nasal clearance in health and disease","volume":"19","author":"Illum","year":"2006","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357022539","article-title":"Is nose-to-brain transport of drugs in man a reality?","volume":"56","author":"Illum","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0110","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1359-6446(02)02529-1","article-title":"Nasal drug delivery: new developments and strategies","volume":"7","author":"Illum","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0115","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0120","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s11095-012-0915-1","article-title":"Intranasal treatment of central nervous system dysfunction in humans","volume":"30","author":"Chapman","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pediatrneurol.2005.09.006","article-title":"Intranasal midazolam vs rectal diazepam in acute childhood seizures","volume":"34","author":"Bhattacharyya","year":"2006","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0130","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1528-1167.2010.02949.x","article-title":"Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study","volume":"52","author":"Arya","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0135","first-page":"22","article-title":"Nasal cavity: a promising transmucosal platform for drug delivery and research approaches from nasal to brain targeting","volume":"2","author":"Singh","year":"2012","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0140","article-title":"Intranasal drug delivery to brain: an overview","volume":"2","author":"Parvathi","year":"2012","journal-title":"Int. J. Res. Pharm. Chem."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-5173(00)00580-9","article-title":"Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray","volume":"212","author":"Loftsson","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-5173(01)00872-9","article-title":"Intranasal bioavailability of diazepam in sheep correlated to rabbit and man","volume":"231","author":"Lindhardt","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0155","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1208\/s12248-014-9596-5","article-title":"Rapid delivery of diazepam from supersaturated solutions prepared using prodrug\/enzyme mixtures: toward intranasal treatment of seizure emergencies","volume":"16","author":"Kapoor","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0160","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/jps.20600","article-title":"Enhanced permeation of diazepam through artificial membranes from supersaturated solutions","volume":"95","author":"Hou","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/10837459709031449","article-title":"Solubilization of various benzodiazepines for intranasal administration, a pilot study","volume":"2","author":"Bechgaard","year":"1997","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0170","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jps.20480","article-title":"Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting","volume":"95","author":"Vyas","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0175","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.addr.2005.07.009","article-title":"Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives","volume":"57","author":"Ugwoke","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0180","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/jps.22307","article-title":"Intranasal clobazam delivery in the treatment of status epilepticus","volume":"100","author":"Florence","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0185","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1213\/01.ane.0000226150.90317.16","article-title":"Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers","volume":"103","author":"Wermeling","year":"2006","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijpharm.2008.07.030","article-title":"Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits","volume":"364","author":"Kaur","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0195","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.2042-7158.1985.tb05069.x","article-title":"Intranasal drug delivery by spray and drops","volume":"37","author":"Hardy","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-409X(97)00067-7","article-title":"Nasal delivery systems and their effect on deposition and absorption","volume":"29","author":"Kublik","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0205","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1007\/s11095-010-0127-5","article-title":"Intranasal delivery\u2014modification of drug metabolism and brain disposition","volume":"27","author":"Wong","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0210","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nurt.2009.01.002","article-title":"Intranasal delivery of antiepileptic medications for treatment of seizures","volume":"6","author":"Wermeling","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(97)00063-X","article-title":"Effects of physicochemical properties and other factors on systemic nasal drug delivery","volume":"29","author":"Romeo","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0220","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal drug delivery: how, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0225","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yebeh.2015.04.027","article-title":"Intranasal therapies for acute seizures","volume":"49","author":"Kalviainen","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","article-title":"Nasal mucociliary clearance as a factor in nasal drug delivery","volume":"29","author":"Merkus","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0235","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/1061186021000001823","article-title":"Visualization of in vivo olfactory uptake and transfer using fluorescein dextran","volume":"10","author":"Jansson","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0240","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/cancers5031020","article-title":"Formulations for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM?","volume":"5","author":"van Woensel","year":"2013","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0245","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1015830907632","article-title":"The nasal mucociliary clearance: relevance to nasal drug delivery","volume":"8","author":"Schipper","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery - possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0255","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/01926230600713475","article-title":"The nose revisited: a brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium","volume":"34","author":"Harkema","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0260","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1124\/jpet.108.145565","article-title":"Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system","volume":"328","author":"Dhuria","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0265","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0364-7722(82)80103-3","article-title":"Discriminative stimulus properties of the vasodilator, hydralazine: differential generalization with alpha1 and alpha2 adrenoreceptor drugs","volume":"6","author":"Bennett","year":"1982","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0270","first-page":"371","article-title":"Vasodilator effects of clonidine on the mesenteric arterial beds in normotensive and spontaneously hypertensive rats","volume":"84","author":"Kamata","year":"1994","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0275","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejps.2005.01.009","article-title":"Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents","volume":"24","author":"Westin","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0280","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11095-004-1191-5","article-title":"Pharmacokinetics of substrate uptake and distribution in murine brain after nasal instillation","volume":"22","author":"Graff","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0285","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11095-004-9013-3","article-title":"Functional evidence for P-glycoprotein at the nose-brain barrier","volume":"22","author":"Graff","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0290","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/jps.20318","article-title":"Nasal drug administration: potential for targeted central nervous system delivery","volume":"94","author":"Graff","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0295","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1023\/A:1025053115583","article-title":"P-glycoprotein attenuates brain uptake of substrates after nasal instillation","volume":"20","author":"Graff","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0300","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/PEC.0b013e3180328c92","article-title":"Prehospital intranasal midazolam for the treatment of pediatric seizures","volume":"23","author":"Holsti","year":"2007","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0305","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/B:PHAR.0000026823.82950.ff","article-title":"Nasal route and drug delivery systems","volume":"26","author":"Turker","year":"2004","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0310","first-page":"516","article-title":"A review on nose-to-brain drug delivery","volume":"2","author":"Kamble","year":"2013","journal-title":"Int. J. Pharm. Chem. Biol. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0315","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.2042-7158.1992.tb05462.x","article-title":"Diiodo l tyrosine labelled dextrans as molecular size markers of nasal absorption in the rat","volume":"44","author":"Fisher","year":"1992","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0320","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2009.05.057","article-title":"Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits","volume":"378","author":"Yu","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0325","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2273.1999.00223.x","article-title":"Nasal pH measurement: a reliable and repeatable parameter","volume":"24","author":"England","year":"1999","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0330","first-page":"418","article-title":"Mucoadhesive polymers: means of improving the mucoadhesive properties of drug delivery system","volume":"2","author":"Yadav","year":"2010","journal-title":"J. Chem. Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0335","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejps.2014.04.019","article-title":"Intranasal administration of carbamazepine to mice: a direct delivery pathway for brain targeting","volume":"60","author":"Serralheiro","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0340","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1208\/s12248-012-9325-x","article-title":"Pharmacokinetic evaluation of intranasally administered vinyl polymer-coated lorazepam microparticles in rabbits","volume":"14","author":"Zhao","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0345","article-title":"Evaluation of brain-targeting for the nasal delivery of midazolam","volume":"12","author":"Desai","year":"2012","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0350","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0021-8502(86)90035-2","article-title":"Deposition of particles in the human respiratory tract in the size range 0.005\u201315\u03bcm","volume":"17","author":"Heyder","year":"1986","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0355","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0021-8502(73)90063-3","article-title":"Regional deposition and clearance of particles in the human nose","volume":"4","author":"Fry","year":"1973","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0360","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","article-title":"Nasal drug delivery devices: characteristics and performance in a clinical perspective - a review","volume":"3","author":"Djupesland","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0365","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nurt.2009.02.001","article-title":"Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles","volume":"6","author":"Kubek","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0370","doi-asserted-by":"crossref","first-page":"A758","DOI":"10.1289\/ehp.113-a758a","article-title":"Particles in practice: how ultrafines disseminate in the body","volume":"113","author":"Weinhold","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0375","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1248\/cpb.33.2149","article-title":"Comparison of water influx and sieving coefficient in rat jejunal, rectal and nasal absorptions of antipyrine","volume":"33","author":"Hayashi","year":"1985","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0380","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2147\/IJN.S61288","article-title":"Current approaches to enhance CNS delivery of drugs across the brain barriers","volume":"9","author":"Lu","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0385","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijpharm.2004.01.039","article-title":"Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain","volume":"275","author":"Zhang","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0390","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.MLG.0000199741.08517.99","article-title":"Breath actuated device improves delivery to target sites beyond the nasal valve","volume":"116","author":"Djupesland","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0395","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2273.2002.00544.x","article-title":"Nasal mucosal temperature during respiration","volume":"27","author":"Lindemann","year":"2002","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0400","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1365-2273.2000.00420.x","article-title":"The effect of hypertonicity on nasal mucociliary clearance","volume":"25","author":"Homer","year":"2000","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0405","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0410","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.neuropharm.2008.08.032","article-title":"Several major antiepileptic drugs are substrates for human P-glycoprotein","volume":"55","author":"Luna-Tortos","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0420","first-page":"359","article-title":"Allergic reaction to intranasal midazolam HCl: a case report","volume":"26","author":"Mcilwain","year":"2004","journal-title":"Pediatr. Dent."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0425","series-title":"Respiratory Drug Delivery IX","first-page":"773","article-title":"Cyclodextrins in pulmonary drug delivery: in vitro toxicity of cyclodextrins in Calu-3 cells","author":"Kinnarinen","year":"2004"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0430","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1023\/A:1023079322024","article-title":"Cyclodextrins","volume":"44","author":"Magn\u00fasd\u00f3ttir","year":"2002","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0435","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2125.1995.tb04476.x","article-title":"Absorption of clonazepam after intranasal and buccal administration","volume":"39","author":"Schols-Hendriks","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0440","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/03639040801926063","article-title":"Development of a cyclodextrin-based nasal delivery system for lorazepam","volume":"34","author":"Jug","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0445","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.2042-7158.1997.tb06105.x","article-title":"Pharmacokinetic and pharmacodynamic response after intranasal administration of diazepam to rabbits","volume":"49","author":"Bechgaard","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0450","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1211\/0022357991772565","article-title":"Single- and repeated-dose local toxicity in the nasal cavity of rabbits after intranasal administration of different glycols for formulations containing benzodiazepines","volume":"51","author":"Hjortkjer","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0455","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0378-5173(00)00373-2","article-title":"Rapid-onset intranasal delivery of anticonvulsants: pharmacokinetic and pharmacodynamic evaluation in rabbits","volume":"199","author":"Li","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0460","unstructured":"D.P. Wermeling, System and method for intranasal administration of lorazepam, in, Google Patents, 2003."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0465","first-page":"1825","article-title":"Microemulsions for nasal drug delivery systems: an overview","volume":"5","author":"Mahajan","year":"2013","journal-title":"Int. J. Pharm. Sci. Tech."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0470","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-5173(02)00029-7","article-title":"Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam","volume":"237","author":"Li","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0475","first-page":"642","article-title":"Preparation of lorazepam-loaded microemulsions for intranasal delivery and its pharmacokinetics","volume":"64","author":"Yao","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0480","doi-asserted-by":"crossref","DOI":"10.4236\/pp.2011.23026","article-title":"Intranasal delivery of two benzodiazepines, midazolam and diazepam, by a microemulsion system","volume":"2","author":"Botner","year":"2011","journal-title":"Pharmacol. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0485","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/app.22390","article-title":"Biocompatible polymer blends: effects of physical processing on the molecular interaction of poly(vinyl alcohol) and poly(vinyl pyrrolidone)","volume":"98","author":"Jones","year":"2005","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0490","first-page":"363","article-title":"Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model","volume":"6","author":"Eskandari","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0495","first-page":"1","article-title":"Dissolution of amorphous solid dispersions: theory and practice","volume":"10","author":"Fotaki","year":"2014","journal-title":"Adv. Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0500","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/jps.24541","article-title":"Amorphous solid dispersions: utilization and challenges in drug discovery and development","volume":"104","author":"He","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0505","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/js980403l","article-title":"Solid dispersion of poorly water-soluble drugs: early promises subsequent problems, and recent breakthroughs","volume":"88","author":"Serajuddin","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0510","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-0404.2009.01170.x","article-title":"Pharmacokinetics and tolerability of intranasal diazepam and midazolam in healthy adult volunteers","volume":"120","author":"Ivaturi","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0515","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1021\/mp400272m","article-title":"Prodrug\/enzyme based acceleration of absorption of hydrophobic drugs: an in vitro study","volume":"10","author":"Kapoor","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0520","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejps.2016.04.018","article-title":"Development and application of an ex vivo fosphenytoin nasal bioconversion\/permeability evaluation method","volume":"89","author":"Viegas","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0525","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.2042-7158.1990.tb05401.x","article-title":"On the use of diazepam and pro-diazepam (2-benzoyl-4-chloro-N-methyl-N-lysylglycin anilide), as adjunct antidotes in the treatment of organophosphorus intoxication in the guinea-pig","volume":"42","author":"Karlsson","year":"1990","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0530","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1476-5381.2009.00330.x","article-title":"Bioavailability of diazepam after intramuscular injection of its water-soluble prodrug alone or with atropine-pralidoxime in healthy volunteers","volume":"157","author":"Abbara","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0535","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1021\/acs.jafc.5b01665","article-title":"Flavourzyme, an enzyme preparation with industrial relevance: automated nine-step purification and partial characterization of eight enzymes","volume":"63","author":"Merz","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0540","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.yebeh.2015.05.004","article-title":"Water-soluble benzodiazepine prodrug\/enzyme combinations for intranasal rescue therapies","volume":"49","author":"Siegel","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2016.05.011","article-title":"Chirally pure prodrugs and their converting enzymes lead to high supersaturation and rapid transcellular permeation of benzodiazepines","author":"Kapoor","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0550","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/0192623391019004-102","article-title":"Comparative aspects of nasal airway anatomy: relevance to inhalation toxicology","volume":"19","author":"Harkema","year":"1991","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0555","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jen.2004.01.006","article-title":"Intranasal drug delivery: an alternative to intravenous administration in selected emergency cases","volume":"30","author":"Wolfe","year":"2004","journal-title":"J. Emerg. Nurs."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0560","first-page":"111","article-title":"Deposition pattern of nasal sprays in man","volume":"26","author":"Newman","year":"1988","journal-title":"Rhinology"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0565","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jps.2600770412","article-title":"Effects of concentration and volume on nasal bioavailability and biological response to desmopressin","volume":"77","author":"Harris","year":"1988","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0570","unstructured":"http:\/\/www.lmaco.com\/products\/lma-mad-nasal, Teleflex LMA, (2015)."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0580","unstructured":"http:\/\/mysticpharmaceuticals.com\/delivery-platforms\/versidoser-and-vrx2-delivery-platforms\/, Mystic Pharmaceuticals, (2014)."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0585","unstructured":"http:\/\/www.kurvetech.com\/devices.asp, Kurve Technology, (2015)."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0595","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.eplepsyres.2013.02.018","article-title":"A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers","volume":"105","author":"Agarwal","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0600","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/511S12a","article-title":"Drug development: illuminated targets","volume":"511","author":"Cully","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0605","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","article-title":"Quantitative analysis of drug delivery to the brain via nasal route","volume":"189","author":"Kozlovskaya","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0610","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yebeh.2014.06.023","article-title":"Seizure detection, seizure prediction, and closed-loop warning systems in epilepsy","volume":"37","author":"Ramgopal","year":"2014","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0615","series-title":"Predict Seizures in Intracranial EEG Recordings","year":"2014"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0620","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/511S16a","article-title":"Technology: dressed to detect","volume":"511","author":"Dolgin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0635","series-title":"A Novel Formulation of Intranasal Midazolam, at 66th Annual Meeting of the American Academy of Neurology","article-title":"Upsher-Smith presents favorable phase I data for USL261","year":"2014"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0640","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2125.2002.01588.x","article-title":"Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers","volume":"53","author":"Knoester","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2016.07.001_bb0645","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1059-1311(95)80003-4","article-title":"Mechanisms of action of antiepileptic drugs","volume":"4","author":"Davies","year":"1995","journal-title":"Seizure"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0650","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate","volume":"16","author":"Loscher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jconrel.2016.07.001_bb0655","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916304266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916304266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T13:26:54Z","timestamp":1536586014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916304266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":126,"alternative-id":["S0168365916304266"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.07.001","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of intranasal formulations for the treatment of seizure emergencies","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}